Skip to main content
Arthroplasty Today logoLink to Arthroplasty Today
. 2026 Jul 9;40:102042. doi: 10.1016/j.artd.2026.102042

Impact of Central Sensitization and Pain Catastrophizing on Patient-Reported Outcomes Differs Between Unicompartmental and Total Knee Arthroplasties

Kohei Kawaguchi a,b,∗, Ryota Yamagami a, Kenichi Kono a, Shuji Taketomi a, Mei Lin Tay c, Simon W Young b,c, Hiroshi Inui d, Sakae Tanaka a
PMCID: PMC13382020  PMID: 42519226

Abstract

Background

Psychological factors have been reported to influence postoperative clinical outcomes following knee arthroplasties. The present study aimed to examine the association between preoperative central sensitization and pain catastrophizing and postoperative outcomes in patients undergoing unicompartmental knee arthroplasty (UKA) vs total knee arthroplasty (TKA).

Methods

This prospective cohort study included 353 patients divided into 2 groups according to the surgical procedure: UKA (n = 72) and TKA (n = 281). The Central Sensitization Inventory (CSI) and Pain Catastrophizing Scale (PCS) questionnaires were administered preoperatively, and patient-reported outcome measures (PROMs) were evaluated according to the subscales of the Knee Injury and Osteoarthritis Outcome Score 1 year postoperatively. Preoperative CSI and PCS scores were compared between patients undergoing UKA vs TKA, and the correlations with PROMs were analyzed.

Results

The mean (± standard deviation) preoperative CSI and PCS scores were 21.4 ± 10.5 and 27.3 ± 10.8 for the UKA group, and 22.6 ± 14.1 and 26.2 ± 12.9 for the TKA group; however, the differences in these scores between the groups were not statistically significant (P = .51 and P = .53, respectively). CSI and PCS scores exhibited no correlation with any postoperative subscale in PROMs (all subscales in Knee Injury and Osteoarthritis Outcome Score) in UKA. However, CSI and PCS scores exhibited negative correlations with all subscales in PROMs in TKA.

Conclusions

There were no statistical differences in preoperative central sensitization and pain catastrophizing between patients who underwent UKA vs TKA. However, these psychological factors negatively affected postoperative PROMs in patients who underwent TKA, whereas, they were not found to significantly affect postoperative PROMs in the UKA group; however, this finding may reflect limited sample size rather than a true absence of effect.

Keywords: Central sensitization, Pain catastrophizing, Patient-reported outcomes, Total knee arthroplasty, Unicompartmental knee arthroplasty

Introduction

Postoperative patient-reported outcome measures (PROMs) for total knee arthroplasty (TKA) have become popular as an alternative to subjective evaluations [1]. In fact, the results of studies using PROMs have reported that approximately 10 to 20% of patients were not satisfied after undergoing TKA [2,3]. Various risk factors for dissatisfaction with TKA have been investigated [4,5]. Preoperative psychological factors, such as central sensitization to pain, catastrophic thinking refers to a cognitive response that amplifies the perceived threat and severity of pain, depression, pessimistic thinking refers to a cognitive response that leads individuals to anticipate poorer outcomes and emphasize potential complications related to their condition or treatment, and low motivation, have been reported to influence postoperative PROMs [[6], [7], [8], [9]]. In particular, central sensitization and pain catastrophizing have been identified as preoperative psychiatric factors for postoperative dissatisfaction and painful knees after TKA [10].

Central sensitization is a condition characterized by chronic pain due to modulation of the central nervous system, reflected by sustained stimulation of peripheral nociceptors, causing inactivation of the descending inhibitory system. Typical symptoms of central sensitization include hyperalgesia, allodynia, and persistent pain [11]. It has been reported that 20%–40% of patients with advanced knee osteoarthritis already experience central sensitization to pain [12] and central sensitization has recently been the focus of interest as a potential cause of persistent pain and discomfort after TKA [13].

Pain catastrophizing is defined as an exaggerated negative reaction to real and/or imaged pain [14]. Pain catastrophizing is a process in which the experience of pain is viewed pessimistically. When catastrophic thinking is strong, there is excessive fear of pain, which leads to a negative cycle of reduced activity due to behavioral avoidance, resulting in a state of chronic pain [15]. Several studies have reported an association between the postoperative clinical outcomes of TKA and preoperative pain catastrophization [[16], [17], [18], [19]]. Preoperative pain catastrophizing has been found to be associated with poor pain scores [[20], [21], [22]], poor activity, and prolonged hospital stay [23].

Unicompartmental knee arthroplasty (UKA) is performed for single-compartment knee disorders, whereas TKA is typically performed for knee disorders involving 2 or more compartments. In comparisons of postoperative PROMs between the 2 procedures, UKA has been reported to yield superior outcomes than those for TKA [24]. However, it remains unclear whether preoperative central sensitization and pain catastrophizing differ between the 2 procedures, which have different preoperative ranges of motion and degrees of osteoarthritis. Additionally, there have been no studies comparing the effects of these 2 psychological factors on postoperative PROMs between TKA and UKA. The aims of the present study, therefore, were to compare preoperative central sensitization and pain catastrophizing between patients undergoing UKA vs TKA, and to examine the association of the 2 psychological factors with postoperative PROMs in UKA compared with TKA.

Material and methods

This was a cohort study of patients scheduled for elective primary knee arthroplasty and analyzed retrospectively when data were completed. Patients were eligible for inclusion in this study if they underwent primary UKA or TKA, had complete preoperative psychological assessments, and ≥1 year(s) of follow-up. In total, data from 353 knee arthroplasties (281 TKA, 72 UKA) from consecutive 534 primary knee arthroplasties performed at the single institution between October 2018 and March 2022 were included. In total, 103 knees, including constrained, postligament reconstruction, and bicruciate-retaining TKA, were excluded. Patients with psychiatric disorders (schizophrenia) who required psychiatric intervention during their hospitalization were excluded (n = 5), those without psychological assessments (n = 33), those with postoperative complications (n = 5), and those lost to follow-up (n = 35) were also excluded (Fig. 1), and bilateral cases were assessed separately. Preoperative psychological measurements and associations between preoperative psychological measures and postoperative PROMs were compared for UKA and TKA. The institutional review board approved this study (No.2674). The patients and their families were notified that their anonymized case data would be published, and all patients provided informed written consent. This retrospective observational study was reported in accordance with the STROBE statement.

Figure 1.

Figure 1

Flowchart of included and excluded patients in this prospective cohort study.

Surgical procedures

All UKA patients received the same mobile-bearing medial UKA implant (Oxford Medial Partial Knee; Zimmer Biomet, Warsaw, NJ, USA) for medial knee osteoarthritis (n = 52) or osteonecrosis of the femoral condyle (n = 20). No lateral UKA was observed in this study. Surgical procedures and postoperative clinical protocols were standardized. The approach used a microplasty system and image-free navigation system (Precision N, Stryker Orthopedics, Mahwah, NJ, USA). For TKA, the implants used were the Journey II bicruciate substituting system (Smith & Nephew, Memphis, TN, USA; n = 224), a posterior-stabilized, fixed-bearing, dual-radius design; the GMK Sphere (Medacta, Castel San Pietro, Switzerland; n = 34), a cruciate-substituting, fixed-bearing, single-radius design; and the Vanguard ROCC (Zimmer Biomet; n = 23), a cruciate-substituting, mobile-bearing, multi-radius design. These implants were used in patients with osteoarthritis or moderate osteonecrosis. The choice of implant was based on patient knee deformity and surgeon preference. Surgical methods were standardized across the 3 implants, including coronal alignment strategy, surgical approach, cemented fixation, and layered closure without a drainage tube. The medial parapatellar approach was performed using an image-free navigation system (Precision N) to achieve coronal mechanical alignment in all cases. Full weight-bearing and rehabilitation were started the day after surgery for both procedures. All UKA and TKA procedures were performed by 4 experienced senior surgeons. All patients followed the same rehabilitation protocol in both UKA and TKA. On postoperative day 1, range of motion exercises and assisted walking with a walker were initiated, followed by progression to walking using a crutch. Patients were typically discharged 2 weeks after surgery and completed their rehabilitation with physiotherapists on an outpatient basis.

Preoperative psychological examination

All patients were assessed for preoperative psychological conditions when they were admitted to the hospital 1 day before surgery. Central sensitization was assessed using the Central Sensitization Inventory (CSI) questionnaire, which is a validated self-reported inventory for evaluation of patients with central sensitization [25,26]. The inventory uses a 25-item questionnaire to evaluate somatic and emotional symptoms, and pain-sensitivity experiences. Each item is graded on a 5-point Likert scale ranging from 0 to 4 points (0 = never; 1 = rarely; 2 = sometimes; 3 = often; and 4 = always). The CSI score ranges from 0 to 100, with 0 representing the best score and 100 representing the worst score [26]. A CSI score threshold of 40 was used to categorize patients into high and low CSI groups; this threshold has been widely to detect patients with the central sensitization in previous studies [[27], [28], [29]]. Pain catastrophizing was evaluated using the Pain Catastrophizing Scale (PCS), which includes 3 different elements: helplessness, rumor, and enhancement [14,30]. The PCS consists of 13 items, each of which is graded on a 5-point Likert scale ranging from 0 to 4 points (0 = not at all; 1 = slight; 2 = moderate; 3 = great; and 4 = all the time). The PCS score ranges from 0 to 52, with 0 representing the best score and 52 representing the worst. A threshold of 30 points was used to identify the high PCS score group based on previous studies regarding knee osteoarthritis [10,22].

Postoperative clinical outcomes

Postoperative clinical outcomes were evaluated in accordance with the 2022 Knee Society Scoring System (KSS) [31] and the Knee Injury and Osteoarthritis Outcome Score (KOOS) [32] at the 1-year postoperative clinic. Four separate categories in the KSS (objective knee score, patient satisfaction score, patient expectation score, and functional knee score) and 5 separate categories in the KOOS (pain, symptoms, activities of daily living, sports, and quality of life) were evaluated. Knee range of motion was also measured preoperatively using a standard clinical goniometer when the patients were admitted to the hospital 1 day before surgery.

Statistical analysis

Statistical analyses were performed using SPSS version 25.0 (IBM Corp., Armonk, NY, USA). To compare TKA with UKA, comparisons of means were performed using either the Mann–Whitney U test or the independent t-test, depending on the normality of continuous variables was assessed using the Shapiro–Wilk test. Correlations between psychological measures and postoperative PROMs were analyzed using Pearson’s correlation coefficients. To investigate the impact of psychological measurements on PROMs, multivariable regression analyses were conducted, considering factors such as age at surgery, time interval since surgery, body mass index (BMI), sex, preoperative knee flexion angle and preoperative knee extension angle, and the psychological factor (CSI or PCS) in TKA and UKA. All statistical tests were 2-tailed, and differences with P < .05 were considered to be significant. Before this investigation, a power analysis was performed using G∗Power version 3.1.9.4 (Heinrich-Heine University, Düsseldorf, Germany). Using an effect size of 0.5, this required a sample size >64 in each group (1 – β = 0.80, α = 0.05).

Results

Preoperative demographic data are summarized in Table 1. There were no differences in age, BMI, or laterality between the UKA and TKA groups; however, there were more males and better preoperative knee range of motion in the UKA group than those in the TKA group. The mean (± standard deviation) preoperative CSI and PCS scores were 22.6 ± 14.1 and 26.2 ± 12.9 in the TKA group, and 21.4 ± 10.5 and 27.3 ± 10.8 in the UKA group, respectively; however, there were no statistical differences between the groups (Fig. 2). The proportion of patients in the high CSI group was similar, with 12.8% (36/281 knees) in the TKA group and 5.6% (4/72 knees) in the UKA group (P = .09). The proportion of patients in the high PCS group was also similar, with 39.5% (111/281 knees) in the TKA group and 48.6% (35/72 knees) in the UKA group (P = .16).

Table 1.

Preoperative patient demographics in total knee arthroplasty (TKA) and unicompartmental knee arthroplasty (UKA).

Items TKA UKA P value
Knees (patients) 281 (240) 72 (68)
Age (years old) 73.3 ± 8.6 72.8 ± 10.2 .69
Height (m) 1.53 ± 0.08 1.57 ± 0.07 <.01a
Weight (kg) 61.1 ± 12.1 61.9 ± 12.8 .63
BMI (kg/m2) 25.7 ± 4.2 25.0 ± 4.0 .19
Women: men 231 : 50 48 : 42 <.01a
Right: left 144 : 137 37 : 35 .98
Knee extension angle (°) 7.8 ± 7.6 3.4 ± 3.4 <.01a
Knee flexion angle (°) 119.0 ± 17.5 131.3 ± 8.4 <.01a
a

P < .05.

Figure 2.

Figure 2

Comparison between total knee arthroplasty and unicompartmental knee arthroplasty in Central Sensitization Inventory and Pain Catastrophizing Scale. CSI, central sensitization inventory, ns, not significantly different, the box represents the interquartile range (IQR) and median of the data.

Comparing postoperative PROMs between the UKA and TKA groups, UKA had better outcomes in terms of the Pain and Sports score in the KOOS; however, TKA had better satisfaction scores and objective knee score in the KSS (Table 2). Regarding the relationship between psychological factors and PROMs, preoperative CSI and PCS scores were negatively correlated with all postoperative PROMs for TKA; however, preoperative CSI and PCS scores were not correlated with all postoperative PROMs for UKA (Tables 3 and 4, Figs. 3 and 4). Multivariable regression analysis, including age, BMI, sex, knee flexion and extension angle, and psychological factors (CSI or PCS), showed CSI and PCS were influential factors for all postoperative PROMs for TKA, while CSI and PCS were not significant influential factors in UKA (Tables 5 and 6). The high CSI group exhibited inferior PROMs in TKA; however, there was no difference between the high CSI and control groups in UKA (Table 7). The high PCS group exhibited inferior PROMs, except for the KOOS symptom score in TKA; however, there was no difference between the high PCS group and the control group, except for functional score in UKA (Table 8).

Table 2.

Postoperative patient-reported outcome measures (PROMs) and knee range of motion in total knee arthroplasty (TKA) and unicompartmental knee arthroplasty (UKA).

Items TKA UKA P value
KOOS
 Pain 85.9 ± 14.6 90.3 ± 9.9 .02a
 Symptoms 84.9 ± 12.2 86.0 ± 11.0 .52
 ADL 84.4 ± 14.1 87.0 ± 10.5 .15
 Sports 52.7 ± 27.3 63.5 ± 24.1 <.01a
 QOL 68.8 ± 21.7 69.2 ± 19.7 .91
KSS
 Objective knee score 19.9 ± 3.6 18.5 ± 6.3 .08
 Patient satisfaction score 28.8 ± 8.1 26.1 ± 10.4 .04a
 Patient expectation score 10.1 ± 2.9 10.8 ± 2.9 .06
 Functional knee score 71.9 ± 18.7 70.2 ± 20.7 .49
 Knee range of motion (°) 122.0 ± 14.8 130.5 ± 9.2 <.01a

Average ±standard deviation.

KSS, 2022 Knee Society Scoring System; ADL, activities of daily living; QOL, quality of life.

a

P < .05.

Table 3.

Correlation of preoperative Central Sensitization Inventory (CSI) and postoperative patient-reported outcome measures (PROMs) in total knee arthroplasty (TKA) and unicompartmental knee arthroplasty (UKA).

PROMs TKA
UKA
Correlation coefficient 95% CI P value Correlation coefficient 95% CI P value
KOOS
 Pain −0.35 −0.45 −0.23 <.01a −0.17 −0.39 0.07 0.17
 Symptoms −0.34 −0.44 −0.22 <.01a −0.20 −0.42 0.04 0.09
 ADL −0.33 −0.43 −0.21 <.01a −0.15 −0.38 0.08 0.21
 Sports −0.20 −0.32 −0.07 <.01a −0.16 −0.39 0.07 0.18
 QOL −0.27 −0.38 −0.14 <.01a −0.14 −0.37 0.10 0.25
KSS
 Objective knee score −0.27 −0.38 −0.14 <.01a −0.10 −0.33 0.13 0.38
 Patient satisfaction score −0.29 −0.40 −0.16 <.01a −0.11 −0.33 0.13 0.35
 Patient expectation score −0.16 −0.28 −0.03 .01a −0.01 −0.24 0.23 0.95
 Functional knee score −0.30 −0.41 −0.17 <.01a −0.12 −0.35 0.12 0.34

PROMs, patient-reported outcomes; KSS, 2022 Knee Society Scoring System; ADL, activities of daily living; QOL, quality of life; 95% CI, 95% confidence interval.

a

P < .05.

Table 4.

Correlation of preoperative Pain Catastrophizing Scale (PCS) and postoperative patient-reported outcome measures (PROMs) in total knee arthroplasty (TKA) and unicompartmental knee arthroplasty (UKA).

Items TKA
UKA
Correlation coefficient 95% CI P value Correlation coefficient 95% CI P value
KOOS
 Pain −0.21 −0.32 −0.08 <.01a −0.04 −0.28 0.19 0.71
 Symptoms −0.14 −0.26 −0.01 .02a −0.02 −0.26 0.21 0.82
 ADL −0.22 −0.33 −0.10 <.01a −0.20 −0.42 0.03 0.08
 Sports −0.21 −0.32 −0.10 <.01a −0.16 −0.38 0.08 0.20
 QOL −0.25 −0.36 −0.12 <.01a −0.11 −0.34 0.13 0.36
KSS
 Objective knee score −0.20 −0.32 −0.07 <.01a −0.17 −0.39 0.06 0.14
 Patient satisfaction score −0.23 −0.34 −0.10 <.01a −0.19 −0.41 0.04 0.10
 Patient expectation score −0.18 −0.30 −0.05 <.01a −0.15 −0.38 0.08 0.19
 Functional knee score −0.21 −0.33 −0.08 <.01a −0.23 −0.45 0.03 0.05

KSS, 2022 Knee Society Scoring System; ADL, activities of daily living; QOL, quality of life; 95% CI, 95% confidence interval.

a

P < .05.

Figure 3.

Figure 3

Correlations between Central Sensitization Inventory (CSI) scores and KOOS subscale scores in TKA and UKA groups. CSI scores exhibited no correlation with any postoperative subscales in KOOS in the UKA group, whereas, CSI scores exhibited negative correlations with all subscales in KOOS in the TKA group. ADL, activities of daily living; QOL, quality of life; CSI, central sensitization inventory; the Pearson correlation coefficients (r) and corresponding P values between preoperative CSI scores and each subscale of the Knee Injury and Osteoarthritis Outcome Score (KOOS).

Figure 4.

Figure 4

Correlations between Pain Catastrophizing Scale (PCS) scores and KOOS subscale scores in TKA and UKA groups. PCS scores exhibited no correlation with any postoperative subscales in KOOS in the UKA group, whereas, PCS scores exhibited negative correlations with all subscales in KOOS in the TKA group. ADL, activities of daily living; QOL, quality of life; PCS, pain catastrophizing scale; the Pearson correlation coefficients (r) and corresponding P values between preoperative PCS scores and each subscale of the Knee Injury and Osteoarthritis Outcome Score (KOOS).

Table 5.

Multivariable analyses of patient-reported outcomes with CSI scores in TKA and UKA.

TKA
PROMs Influential factor β value 95% CI P value
KOOS Pain Age 0.376 0.198 0.553 <.01a
BMI 7.379 2.405 12.353 <.01a
Woman/man 0.725 0.325 1.125 <.01a
Knee flexion angle 0.304 0.199 0.410 <.01a
CSI −0.357 −0.500 −0.214 <.01a
KOOS Symptoms Age 0.571 0.423 0.720 <.01a
BMI 5.693 1.529 9.858 <.01a
Woman/man 0.743 0.409 1.078 <.01a
Knee flexion angle 0.179 0.090 0.267 <.01a
CSI −0.261 −0.380 −0.141 <.01a
KOOS ADL CSI −0.368 −0.498 −0.237 <.01a
KOOS Sports BMI 13.474 4.405 22.544 <.01a
CSI −0.455 −0.718 −0.192 <.01a
KOOS QOL CSI −0.473 −0.682 −0.265 <.01a
KSS objective knee score CSI −0.071 −0.106 −0.036 <.01a
KSS patient satisfaction score CSI −0.177 −0.254 −0.099 <.01a
KSS patient expectation score CSI −0.033 −0.062 −0.005 .02a
KSS functional knee score CSI −0.406 −0.581 −0.230 <.01a
UKA
PROMs Influential factor β value 95% CI P value
KOOS Pain Age 0.404 0.197 0.611 <0.01a
Woman/man 1.040 0.532 1.548 <0.01a
Knee flexion angle 0.267 0.114 0.419 <0.01a
CSI −0.054 −0.292 0.183 0.65
KOOS Symptoms CSI −0.110 −0.386 0.167 0.43
KOOS ADL Age −0.467 −0.761 −0.173 <0.01a
CSI −0.105 −0.354 0.143 0.40
KOOS Sports Age −0.774 −1.475 −0.073 0.03a
CSI −0.257 −0.849 0.335 0.39
KOOS QOL CSI −0.132 −0.647 0.384 0.61
KSS objective knee score CSI −0.031 −0.195 0.134 0.71
KSS patient satisfaction score CSI −0.042 −0.314 0.231 0.76
KSS patient expectation score CSI −0.021 −0.093 0.051 0.55
KSS functional knee score Age −0.697 −1.257 −0.137 0.01a
CSI −0.232 −0.750 0.285 0.37

CSI, central sensitization inventory; KSS, 2022 Knee Society Scoring System; ADL, activities of daily living; QOL, quality of life; PROMs, patient-reported outcome measures; 95% CI, 95% confidence interval.

a

P < .05.

Table 6.

Multivariable analyses of patient-reported outcomes with pain catastrophizing scale (PCS) in TKA and UKA.

TKA
PROMs Influential factor β value 95% CI P value
KOOS Pain PCS −0.253 −0.400 −0.105 <.01a
KOOS Symptoms Age 0.266 0.077 0.456 <.01a
PCS −0.151 −0.273 −0.028 .01a
KOOS ADL BMI 4.842 0.044 9.641 .04a
PCS −0.235 −0.377 −0.093 <.01a
KOOS Sports BMI 14.021 4.993 23.049 <.01a
PCS −0.457 −0.725 −0.189 <.01a
KOOS QOL PCS −0.433 −0.647 −0.218 <.01a
KSS objective knee score PCS −0.058 −0.096 −0.021 <.01a
KSS patient satisfaction score PCS −0.146 −0.229 −0.064 <.01a
KSS patient expectation score PCS −0.045 −0.075 −0.015 <.01a
KSS functional knee score BMI 6.383 0.129 12.637 .04a
Woman/man −0.623 −1.207 −0.039 .03a
PCS −0.317 −0.511 −0.124 <.01a
UKA
PROMs Influential factor β value 95% CI P value
KOOS Pain PCS −0.053 −0.257 0.151 0.61
KOOS Symptoms PCS −0.018 −0.277 0.240 0.89
KOOS ADL Age −0.438 −0.726 −0.150 <0.01a
PCS −0.141 −0.366 0.085 0.22
KOOS Sports Age −0.731 −1.422 −0.040 0.03a
PCS −0.240 −0.782 0.302 0.38
KOOS QOL PCS −0.141 −0.611 0.330 0.55
KSS objective knee score PCS −0.107 −0.264 0.049 0.17
KSS patient satisfaction score PCS −0.172 −0.431 0.087 0.19
KSS patient expectation score Woman/man −0.216 −0.425 −0.007 0.04a
PCS −0.049 −0.123 0.024 0.19
KSS functional knee score Age −0.610 −1.154 −0.066 0.02a
PCS −0.434 −0.961 0.092 0.10

KSS, 2022 Knee Society Scoring System; ADL, activities of daily living; QOL, quality of life; PROMs, patient-reported outcome measures.

a

P < .05.

Table 7.

Comparison of PROMs between high and low central sensitization inventory (CSI).

TKA
UKA
PROMs CSI ≥40 CSI <40 P value CSI ≥40 CSI <40 P value
KOOS
 Pain 73.8 ± 22.0 87.2 ± 12.9 <.01a 84.3 ± 18.5 90.8 ± 9.3 .25
 Symptoms 78.3 ± 13.6 85.7 ± 11.9 <.01a 88.1 ± 9.0 86.2 ± 11.2 .76
 ADL 75.0 ± 19.6 85.5 ± 13.0 <.01a 89.7 ± 14.1 87.0 ± 10.8 .67
 Sports 41.3 ± 33.4 54.2 ± 26.3 .02a 65.0 ± 5.0 62.9 ± 24.8 .88
 QOL 56.3 ± 23.0 70.2 ± 21.1 <.01a 66.7 ± 7.2 69.0 ± 20.3 .84
KSS
 Objective knee score 17.2 ± 4.9 20.1 ± 3.4 <.01a 19.6 ± 1.2 18.5 ± 6.5 .76
 Patient satisfaction score 23.7 ± 9.2 29.4 ± 7.8 <.01a 30.0 ± 5.3 26.0 ± 10.8 .52
 Patient expectation score 9.0 ± 3.0 10.1 ± 2.9 .05 10.3 ± 1.2 10.9 ± 2.9 .74
 Functional knee score 60.2 ± 20.9 73.2 ± 18.1 <.01a 74.6 ± 13.6 69.6 ± 21.2 .68

PROMs, patient-reported outcome measures; CSI, central sensitization inventory; KSS, 2022 Knee Society Scoring System; ADL, activities of daily living; QOL, quality of life.

a

P < .05.

Table 8.

Comparison of PROMs between high and low Pain Catastrophizing Scale (PCS).

TKA
UKA
PROMs PCS ≥30 PCS <30 P value PCS ≥30 PCS <30 P value
KOOS
 Pain 82.8 ± 16.7 87.8 ± 12.9 <.01a 90.4 ± 8.6 90.1 ± 10.8 .91
 Symptoms 83.2 ± 13.2 86.1 ± 11.5 .06 85.5 ± 10.3 86.4 ± 11.8 .72
 ADL 81.0 ± 15.6 86.7 ± 12.8 <.01a 84.4 ± 12.6 89.5 ± 7.5 .05
 Sports 46.7 ± 29.5 56.8 ± 25.0 <.01a 59.9 ± 27.0 67.0 ± 20.8 .22
 QOL 63.4 ± 23.2 72.5 ± 19.8 <.01a 67.8 ± 23.6 70.4 ± 15.3 .59
KSS
 Objective knee score 19.0 ± 4.1 20.4 ± 3.2 <.01a 17.4 ± 6.4 19.6 ± 6.0 .13
 Patient satisfaction score 27.2 ± 8.0 29.8 ± 8.0 .01a 24.0 ± 9.9 28.2 ± 10.7 .09
 Patient expectation score 9.6 ± 2.8 10.3 ± 3.0 .05 10.6 ± 2.8 11.0 ± 3.0 .53
 Functional knee score 66.8 ± 21.0 75.2 ± 16.6 <.01a 64.8 ± 21.6 75.7 ± 18.4 .03a

PROMs, patient-reported outcome measures; KSS, 2022 Knee Society Scoring System; ADL, activities of daily living; QOL, quality of life.

a

P < .05.

Discussion

The most important finding of the present study was the absence of differences in preoperative central sensitization and pain catastrophizing between patients who underwent UKA vs TKA. Although these psychological disorders had little effect on postoperative PROMs in the UKA group, they negatively affected postoperative PROMs in the TKA group. In other words, patients in the TKA group were more influenced by preoperative negative psychological status than those who underwent UKA. In clinical practice, CSI and PCS may be useful as a screening test for preoperative psychological intervention in especially TKA patients.

Although central sensitization and pain catastrophizing have become popular psychological assessments in knee arthroplasty, only one study has compared TKA vs UKA, and only in terms of pain catastrophizing. Birch et al. [16] compared preoperative pain catastrophizing between TKA and UKA using PCS and reported no difference in preoperative PCS scores between the procedures (P = .61). The PCS results are consistent with our results. Additionally, Wood et al. [22] reported that preoperative osteoarthritis grade did not influence preoperative pain catastrophizing status in patients who underwent TKA. Our preoperative knee range of motion in TKA was significantly lower than that in UKA, indicating more severe osteoarthritis in TKA; however, the grade of osteoarthritis did not influence PCS in our study. Whereas, preoperative PCS score before knee arthroplasty has wide variation among reports, with reported means between 12 and 25 points [22,[33], [34], [35]]. The wide range in PCS scores can be attributed to differences in patient characteristics and surgical indications across facilities, regions, and countries [34]. Lin et al. reported this variability in PCS scores among studies in their systematic review on PCS [34]. The proportion of patients with high PCS (PCS ≥30) was approximately 40% in both the UKA and TKA groups, and the PCS scores were relatively high in this patient cohort compared to other studies. Others have reported proportions of high PCS of 11.3% in UKA [36] and 15-27.5% in TKA [35,37,38]. However, in Japan, Hasegawa et al. [39] reported that 41% of patients score in the high PCS group before TKA, and their proportion of high PCS scores was almost the same as that in our study. When reviewing these studies, we could not identify specific reasons for the slightly higher proportion of patients with pain catastrophizing in our cohort; however, this could be related to cultural or epidemiological differences, because Japanese TKA patients have relatively high-grade osteoarthritis. Therefore, the differences in the PCS scores between the TKA and UKA groups should be evaluated in other regions or countries. Regarding central sensitization in knee arthroplasty, there have been no comparative subsidies between TKA and UKA; and, preoperative central sensitization before UKA in particular remains unclear. Our study reports the CSI in UKA for the first time, and the preoperative CSI in UKA was comparable with that in TKA. Several reports have reported preoperative CSI in TKA, with a preoperative average of 24–39 points and proportions of high CSI (CSI ≥40) of 24%–46% [10,27,28,40]. The CSI in this study was relatively lower; however, previous studies were mostly performed in South Korea. Therefore, regional characteristics may contribute to this difference, and further studies in other regions are needed.

Over the past decade, considerable attention has been focused on understanding the influence of psychological factors on TKA outcomes. To the best of our knowledge, this is the first cohort study to assess the relatively underexplored impact of pain catastrophizing and central sensitization on various patient-reported outcomes of both UKA and TKA. In this study, preoperative pain catastrophization and central sensitization negatively affected postoperative patient-reported pain and activity scores in TKA and had little effect on postoperative outcomes in UKA. Only one other study has investigated the influence of pain catastrophizing on outcomes following UKA. de Brauw et al. [36] reported that preoperative pain catastrophizing in patients undergoing UKA did not influence the EuroQol-5 Dimension–Visual Analog Scale and Forgotten Joint Scores, but negatively affected physical function in the KOOS at 1 year postoperatively. This partially aligns with findings of the present study, demonstrating that PCS itself did not correlate with any functional scores, but patients with high PCS scores (PCS>30) exhibited slightly lower functional scores, and there was no difference in pain scores on the KOOS and KSS compared with patients between high and normal PCS patients. Lin et al. systematically reviewed pain catastrophizing and PROMs in TKA and reported that some studies reported the association between the pain catastrophizing and postoperative pain score; however, 4 studies reported no association between pain catastrophizing and the postoperative pain score [34]. The investigators suggested that a multimodal investigation was necessary to explore the predictive fluctuations of pain catastrophizing on postoperative pain scores. To the best of our knowledge, no study has investigated the influence of central sensitization on outcomes after UKA. This study is the first to demonstrate that preoperative central sensitization has little effect on postoperative PROMs in UKA. However, there are several previous studies investigating preoperative central sensitization and postoperative PROMs in TKA [12,27,28,40], and their results are consistent with those of ours.

There appear to be 2 explanations as to why central sensitization and pain catastrophizing are negatively affected in TKA and have less influence on UKA. First is the preservation of native knee structures in the UKA, such as the anterior and posterior cruciate ligament, lateral compartment joint, and constitutional coronal alignment. Previous studies, which included both UKA and TKA, showed that UKA provides superior proprioception compared to TKA. Among TKA designs, cruciate-retaining TKA demonstrated better proprioception than posterior-stabilized TKA, likely due to preservation of the posterior cruciate ligament [41,42]. Additionally, compared with TKA, UKA has superior knee joint awareness (forgotten joint) [43] and better knee kinematics closer to that of the normal knee [44]. These advantages of UKA may not always be reflected in PROMs, and the difference may be small in aggregate analysis. However, patients with psychological problems could be sensitive to the discomfort caused by lower joint awareness and poorer kinematics in TKA. As a result, PROMs in patients undergoing TKA with psychological problems could be lower than in those without these disorders. In contrast, patients feel less discomfort after UKA than after TKA; therefore, PROMs in patients undergoing UKA could be less influenced by pain catastrophizing and central sensitization. Whereas, there is the second and alternative explanation that TKA patients often have worse preoperative PROMs and extensive surgery, therefore psychological factors might show up more in postoperative PROMs simply because there is more room for “dissatisfaction.” However, we do not have sufficient preoperative PROMs during this period; therefore, we will address this in a future study. Additionally, a greater invasiveness of TKA may increase the effect of preoperative psychological factors on postoperative PROMs comparing with a lower invasiveness of UKA.

The present study had several limitations. First, it was not randomized; as such, patient selection bias may have influenced the outcomes and confounding factors, such as smoking, alcohol, or pulmonary disease, may still remain in this nonrandomized study [45]. However, it is clinically impossible to randomly assign patients to TKA and UKA because the surgical indications differ for the 2 procedures. Second, this study was performed at a single institution, and the results may be inconsistent with those of other institutes. PCS and CSI scores vary widely across institutions, regions, and countries; therefore, multiple regional studies are under consideration. Third, preoperative demographics differed according to sex, height, and knee range of motion. However, we performed multivariable regression analysis to compensate for this issue. Fourth, although only a single implant was used for UKA, 3 different implants, which are primarily used at our institution, were included in the TKA group, as we aimed to capture comprehensive TKA patient data within our institutional preoperative psychological dataset. Postoperative PROMs differed slightly among the 3 implants; however, preoperative psychological factors did not differ among the groups (Supplementary Table 1). Further studies with larger cohorts including multiple implant types are needed to confirm these findings. Fifth, although the UKA group included 72 patients, which met the calculated minimum sample size, we acknowledge that the statistical power may have been insufficient to detect small effect sizes in the correlation analyses within this group. Therefore, the absence of significant associations in the UKA subgroup may reflect either a true lack of relationship or a type II error due to limited sample size. This should be considered when interpreting the subgroup results as well. Future studies with larger sample sizes are warranted to confirm these results. Sixth, the thresholds of CSI and PCS have not been established yet, therefore subgroup analysis between high and low CSI and PCS may not be proper and underpowered. However, these thresholds are most popular in available papers and these results are clinically valuable. Seventh, the 1-year follow-up period used in this study could be too short to evaluate long-term clinical outcomes and complications, though there is research indicating that PROMs after TKA show minimal change over a year [46]. Additionally, we could not calculate minimal clinically important differences for PROMs because preoperative PROMs were unavailable for our first several dozen cases. Eighth, this study contains osteoarthritis and osteonecrosis patients. However, there were no differences in CSI and PCS scores between the 2 groups and in PROMs between the 2 (Supplementary Table 2). Finally, larger prospective studies are needed because the present study may have been statistically underpowered, and there is ample potential for type II errors with regard to detecting all relevant outcomes. We are continuously collecting preoperative psychological data from patients undergoing knee arthroplasty, with the dataset now exceeding 1000 patients, and we are planning a worldwide psychological survey.

Conclusions

Preoperative central sensitization and pain catastrophizing did not differ between patients undergoing UKA vs TKA. However, these psychological factors negatively affected postoperative PROMs in patients who underwent TKA, whereas, they were not found to significantly affect postoperative PROMs in the UKA group; however, this finding may reflect limited sample size rather than a true absence of effect. Clinically, there may be less need to account for preoperative psychological status in patients undergoing UKA; however, preoperative psychological status in those undergoing TKA is not negligible, and intervention would likely improve postoperative PROMs.

Ethics statement

The institutional review board at the Tokyo University Hospital approved this retrospective study.

The patients and their families were informed that the patient data will be submitted for publication, and written informed consent was obtained from them.

Data availability

The data used for this study are available on reasonable request in writing to the corresponding author.

CRediT authorship contribution statement

Kohei Kawaguchi: Writing – original draft, Data curation, Conceptualization. Ryota Yamagami: Methodology, Investigation. Kenichi Kono: Methodology, Investigation, Data curation. Shuji Taketomi: Supervision. Mei Lin Tay: Writing – review & editing. Simon W. Young: Writing – review & editing, Supervision. Hiroshi Inui: Writing – review & editing, Methodology. Sakae Tanaka: Writing – review & editing, Supervision.

Conflicts of interest

S.W. Young is on the speakers bureau/paid presentations for Stryker; has stock or stock options in Auckland Orthopaedics Ltd, Axis Sports Medicine, Surgical Solutions; and receives research support from Stryker and Smith & nephew; all other authors declare no potential conflicts of interest.

For full disclosure statements refer to https://doi.org/10.1016/j.artd.2026.102042.

Appendix A. Supplementary data

Conflict of Interest Statement for Young
mmc1.pdf (271.4KB, pdf)
Conflict of Interest Statement for Kawaguchi
mmc2.pdf (277.8KB, pdf)
Conflict of Interest Statement for Inui
mmc3.pdf (252.5KB, pdf)
Conflict of Interest Statement for Kono
mmc4.pdf (252.4KB, pdf)
Conflict of Interest Statement for Tay
mmc5.pdf (268.6KB, pdf)
Conflict of Interest Statement for Taketomi
mmc6.pdf (253.7KB, pdf)
Conflict of Interest Statement for Tanaka
mmc7.pdf (261.4KB, pdf)
Conflict of Interest Statement for Yamagami
mmc8.pdf (252.6KB, pdf)

Appendix A

.

Supplementary Table 1.

Preoperative psychological factors and postoperative patient-reported outcome measures (PROMs) among 3 total knee arthroplasty (TKA) prostheses

Items TKA prosthesis
P value
Journey Sphere Vanguard
Knees 224 34 23
CSI 22.0 ± 13.5 25.9 ± 15.5 23.4 ± 17.2 .44
PCS 25.7 ± 12.9 28.2 ± 13.5 28.2 ± 13.1 .32
KOOS
 Pain 88.2 ± 11.9a 77.3 ± 20.0a 75.3 ± 21.2a <.01a
 Symptoms 86.2 ± 11.1a 78.6 ± 14.1a 80.8 ± 16.5 <.01a
 ADL 86.5 ± 12.1a 76.8 ± 18.1a 73.8 ± 18.4a .01a
 Sports 54.5 ± 27.4 42.3 ± 27.0 50.3 ± 22.4 .05
 QOL 70.1 ± 21.3a 59.4 ± 23.0a 69.4 ± 21.5 .04a
KSS
 Objective knee score 20.2 ± 3.4a 19.0 ± 4.2 17.1 ± 4.1a <.01a
 Patient satisfaction score 29.8 ± 7.8a 25.5 ± 8.1a 24.2 ± 8.9a .01a
 Patient expectation score 10.1 ± 3.0 9.5 ± 2.7 10.4 ± 2.6 .50
 Functional knee score 74.0 ± 18.1a 66.1 ± 19.0 58.6 ± 18.5a <.01a

Average ±standard deviation.

CSI, central sensitization index; KSS, 2011 Knee Society Score; ADL, activities of daily living; QOL, quality of life; 95% CI, 95% confidence interval.

a

P < .05.

Supplementary Table 2.

Postoperative patient-reported outcome measures (PROMs) and demographic data between osteoarthritis and osteonecrosis knees in unicompartmental knee arthroplasty (UKA)

Items Osteoarthritis Osteonecrosis P value
Knees 52 20
Age (years old) 73.0 ± 11.1 72.3 ± 7.8 .79
BMI (kg/m2) 25.0 ± 3.8 25.0 ± 4.7 .96
CSI 22.5 ± 11.3 18.8 ± 8.0 .18
PCS 28.4 ± 10.8 24.4 ± 10.5 .16
KOOS
 Pain 89.8 ± 9.0 91.7 ± 12.1 .49
 Symptoms 85.1 ± 11.1 88.3 ± 10.7 .31
 ADL 85.6 ± 11.0 90.8 ± 8.3 .07
 Sports 61.8 ± 24.1 68.3 ± 24.0 .32
 QOL 66.6 ± 20.4 76.0 ± 15.8 .08
KSS
 Objective knee score 17.7 ± 6.4 20.5 ± 5.5 .09
 Patient satisfaction score 25.3 ± 10.6 28.3 ± 10.0 .28
 Patient expectation score 10.9 ± 2.7 10.6 ± 3.1 .70
 Functional knee score 67.6 ± 19.8 76.2 ± 22.1 .12

Average ±standard deviation.

CSI, central sensitization index; KSS, 2011 Knee Society Score; ADL, activities of daily living; QOL, quality of life.

STROBE Statement.

Checklist of items that should be included in reports of observational studies

Item no. Recommendation Page No. Relevant text from manuscript (line number)
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract 1 Line 1-2
(b) Provide in the abstract an informative and balanced summary of what was done and what was found 1 Line 5-30
Introduction
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported 2 Line 37-66
Objectives 3 State specific objectives, including any prespecified hypotheses 3 Line 66-68
Methods
Study design 4 Present key elements of study design early in the paper 5 Line 107-123
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection 3-4 Line 72-85
Participants 6 (a) Cohort study—Give the eligibility criteria, and the sources and methods of selection of participants. Describe methods of follow-up
Case-control study—Give the eligibility criteria, and the sources and methods of case ascertainment and control selection. Give the rationale for the choice of cases and controls
Cross-sectional study—Give the eligibility criteria, and the sources and methods of selection of participants
3-4 Line 72-85
(b) Cohort study—For matched studies, give matching criteria and number of exposed and unexposed
Case-control study—For matched studies, give matching criteria and the number of controls per case
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable 6 Line 125-132
Data sources/ measurement 8∗ For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group 6-7 Line 134-146
Bias 9 Describe any efforts to address potential sources of bias 11 Line 256-258
Study size 10 Explain how the study size was arrived at 6-7 Line 134-146
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why 3-4 Line 72-85
Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding 6 Line 135-146
(b) Describe any methods used to examine subgroups and interactions
(c) Explain how missing data were addressed
(d) Cohort study—If applicable, explain how loss to follow-up was addressed
Case-control study—If applicable, explain how matching of cases and controls was addressed
Cross-sectional study—If applicable, describe analytical methods taking account of sampling strategy
6 Line 135-146
(e) Describe any sensitivity analyses
Results
Participants 13∗ (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analyzed 3-4 Line 72-80
(b) Give reasons for nonparticipation at each stage
(c) Consider use of a flow diagram
Descriptive data 14∗ (a) Give characteristics of study participants (eg, demographic, clinical, social) and information on exposures and potential confounders 7 Line 150-152
(b) Indicate number of participants with missing data for each variable of interest
(c) Cohort study—Summarize follow-up time (eg, average and total amount)
Outcome data 15∗ Cohort study—Report numbers of outcome events or summary measures over time 7 Line 152-155
Case-control study—Report numbers in each exposure category, or summary measures of exposure
Cross-sectional study—Report numbers of outcome events or summary measures
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were included 7-8 Line164-171
(b) Report category boundaries when continuous variables were categorized
(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses
Discussion
Key results 18 Summarize key results with reference to study objectives 8 Line 174-180
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any potential bias 11-12 Line 256-283
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence 8 Line 174-180
Generalizability 21 Discuss the generalizability (external validity) of the study results 8-9 Line 192-204
Other information
Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article is based N/A N/A

∗Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies.

An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at www.strobe-statement.org.

References

  • 1.Ramkumar P.N., Harris J.D., Noble P.C. Patient-reported outcome measures after total knee arthroplasty: a systematic review. Bone Joint Res. 2015;4:120–127. doi: 10.1302/2046-3758.47.2000380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bourne R.B., Chesworth B.M., Davis A.M., Mahomed N.N., Charron K.D. Patient satisfaction after total knee arthroplasty: who is satisfied and who is not? Clin Orthop Relat Res. 2010;468:57–63. doi: 10.1007/s11999-009-1119-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.DeFrance M.J., Scuderi G.R. Are 20% of patients actually dissatisfied following total knee arthroplasty? A systematic review of the literature. J Arthroplasty. 2023;38:594–599. doi: 10.1016/j.arth.2022.10.011. [DOI] [PubMed] [Google Scholar]
  • 4.Inui H.Y.R., Kono K., Kawaguchi K. What are the causes of failure after total knee arthroplasty? J Joint Surg Res. 2023;1:9. [Google Scholar]
  • 5.Klem N.R., Smith A., O'Sullivan P., Dowsey M.M., Schütze R., Kent P., et al. What influences patient satisfaction after TKA? A qualitative investigation. Clin Orthop Relat Res. 2020;478:1850–1866. doi: 10.1097/CORR.0000000000001284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ayers D.C., Franklin P.D., Ploutz-Snyder R., Boisvert C.B. Total knee replacement outcome and coexisting physical and emotional illness. Clin Orthop Relat Res. 2005;440:157–161. doi: 10.1097/01.blo.0000185447.43622.93. [DOI] [PubMed] [Google Scholar]
  • 7.Escobar A., Quintana J.M., Bilbao A., Azkárate J., Güenaga J.I., Arenaza J.C., et al. Effect of patient characteristics on reported outcomes after total knee replacement. Rheumatology (Oxford) 2007;46:112–119. doi: 10.1093/rheumatology/kel184. [DOI] [PubMed] [Google Scholar]
  • 8.Gandhi R., Tsvetkov D., Dhottar H., Davey J.R., Mahomed N.N. Quantifying the pain experience in hip and knee osteoarthritis. Pain Res Manag. 2010;15:224–228. doi: 10.1155/2010/578167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Khatib Y., Madan A., Naylor J.M., Harris I.A. Do psychological factors predict poor outcome in patients undergoing tka? A systematic review. Clin Orthop Relat Res. 2015;473:2630–2638. doi: 10.1007/s11999-015-4234-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Koh H.S., Choi Y.H., Park D., Jeong M.G. Association between pain catastrophizing and central sensitization among patients with severe knee osteoarthritis awaiting primary total knee arthroplasty. Orthopedics. 2022;45:197–202. doi: 10.3928/01477447-20220401-06. [DOI] [PubMed] [Google Scholar]
  • 11.Woolf C.J. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152:S2–S15. doi: 10.1016/j.pain.2010.09.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Koh I.J., Kang B.M., Kim M.S., Choi K.Y., Sohn S., In Y. How does preoperative central sensitization affect quality of life following total knee arthroplasty? J Arthroplasty. 2020;35:2044–2049. doi: 10.1016/j.arth.2020.04.004. [DOI] [PubMed] [Google Scholar]
  • 13.Wluka A.E., Yan M.K., Lim K.Y., Hussain S.M., Cicuttini F.M. Does preoperative neuropathic-like pain and central sensitisation affect the post-operative outcome of knee joint replacement for osteoarthritis? A systematic review and meta analysis. Osteoarthritis and cartilage. 2020;28:1403–1411. doi: 10.1016/j.joca.2020.07.010. [DOI] [PubMed] [Google Scholar]
  • 14.Sullivan M., Tanzer M., Stanish W., Fallaha M., Keefe F.J., Simmonds M., et al. Psychological determinants of problematic outcomes following total knee arthroplasty. Pain. 2009;143:123–129. doi: 10.1016/j.pain.2009.02.011. [DOI] [PubMed] [Google Scholar]
  • 15.Turner J.A., Aaron L.A. Pain-related catastrophizing: what is it? Clin J Pain. 2001;17:65–71. doi: 10.1097/00002508-200103000-00009. [DOI] [PubMed] [Google Scholar]
  • 16.Birch S., Stilling M., Mechlenburg I., Hansen T.B. The association between pain catastrophizing, physical function and pain in a cohort of patients undergoing knee arthroplasty. BMC Musculoskelet Disord. 2019;20:421. doi: 10.1186/s12891-019-2787-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Burns L.C., Ritvo S.E., Ferguson M.K., Clarke H., Seltzer Z., Katz J. Pain catastrophizing as a risk factor for chronic pain after total knee arthroplasty: a systematic review. J Pain Res. 2015;8:21–32. doi: 10.2147/JPR.S64730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hovik L.H., Winther S.B., Foss O.A., Gjeilo K.H. Preoperative pain catastrophizing and postoperative pain after total knee arthroplasty: a prospective cohort study with one year follow-up. BMC Musculoskelet Disord. 2016;17:214. doi: 10.1186/s12891-016-1073-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Vissers M.M., Bussmann J.B., Verhaar J.A., Busschbach J.J., Bierma-Zeinstra S.M., Reijman M. Psychological factors affecting the outcome of total hip and knee arthroplasty: a systematic review. Semin Arthritis Rheum. 2012;41:576–588. doi: 10.1016/j.semarthrit.2011.07.003. [DOI] [PubMed] [Google Scholar]
  • 20.Sorel J.C., Veltman E.S., Honig A., Poolman R.W. The influence of preoperative psychological distress on pain and function after total knee arthroplasty: a systematic review and meta-analysis. Bone Joint J. 2019;101b:7–14. doi: 10.1302/0301-620X.101B1.BJJ-2018-0672.R1. [DOI] [PubMed] [Google Scholar]
  • 21.Theunissen M., Peters M.L., Bruce J., Gramke H.F., Marcus M.A. Preoperative anxiety and catastrophizing: a systematic review and meta-analysis of the association with chronic postsurgical pain. Clin J Pain. 2012;28:819–841. doi: 10.1097/AJP.0b013e31824549d6. [DOI] [PubMed] [Google Scholar]
  • 22.Wood T.J., Thornley P., Petruccelli D., Kabali C., Winemaker M., de Beer J. Preoperative predictors of pain catastrophizing, anxiety, and depression in patients undergoing total joint arthroplasty. J Arthroplasty. 2016;31:2750–2756. doi: 10.1016/j.arth.2016.05.056. [DOI] [PubMed] [Google Scholar]
  • 23.Witvrouw E., Pattyn E., Almqvist K.F., Crombez G., Accoe C., Cambier D., et al. Catastrophic thinking about pain as a predictor of length of hospital stay after total knee arthroplasty: a prospective study. Knee Surg Sports Traumatol Arthrosc. 2009;17:1189–1194. doi: 10.1007/s00167-009-0817-x. [DOI] [PubMed] [Google Scholar]
  • 24.Peersman G., Verhaegen J., Favier B. The forgotten joint score in total and unicompartmental knee arthroplasty: a prospective cohort study. Int Orthop. 2019;43:2739–2745. doi: 10.1007/s00264-019-04342-w. [DOI] [PubMed] [Google Scholar]
  • 25.Mayer T.G., Neblett R., Cohen H., Howard K.J., Choi Y.H., Williams M.J., et al. The development and psychometric validation of the central sensitization inventory. Pain Pract. 2012;12:276–285. doi: 10.1111/j.1533-2500.2011.00493.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Neblett R., Cohen H., Choi Y., Hartzell M.M., Williams M., Mayer T.G., et al. The central sensitization inventory (csi): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J Pain. 2013;14:438–445. doi: 10.1016/j.jpain.2012.11.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kim M.S., Koh I.J., Choi K.Y., Ju G.I., In Y. Centrally sensitized patients undergoing total knee arthroplasty have higher expectations than do non-centrally sensitized patients. Knee Surg Sports Traumatol Arthrosc. 2022;30:1257–1265. doi: 10.1007/s00167-021-06561-4. [DOI] [PubMed] [Google Scholar]
  • 28.Kim M.S., Koh I.J., Sohn S., Kang B.M., Kwak D.H., In Y. Central sensitization is a risk factor for persistent postoperative pain and dissatisfaction in patients undergoing revision total knee arthroplasty. J Arthroplasty. 2019;34:1740–1748. doi: 10.1016/j.arth.2019.03.042. [DOI] [PubMed] [Google Scholar]
  • 29.Neblett R., Hartzell M.M., Mayer T.G., Cohen H., Gatchel R.J. Establishing clinically relevant severity levels for the central sensitization inventory. Pain Pract. 2017;17:166–175. doi: 10.1111/papr.12440. [DOI] [PubMed] [Google Scholar]
  • 30.Osman A., Barrios F.X., Kopper B.A., Hauptmann W., Jones J., O'Neill E. Factor structure, reliability, and validity of the pain catastrophizing scale. J Behav Med. 1997;20:589–605. doi: 10.1023/a:1025570508954. [DOI] [PubMed] [Google Scholar]
  • 31.Noble P.C., Scuderi G.R., Brekke A.C., Sikorskii A., Benjamin J.B., Lonner J.H., et al. Development of a new knee society scoring system. Clin Orthop Relat Res. 2012;470:20–32. doi: 10.1007/s11999-011-2152-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Nakamura N., Takeuchi R., Sawaguchi T., Ishikawa H., Saito T., Goldhahn S. Cross-cultural adaptation and validation of the japanese knee injury and osteoarthritis outcome score (koos) J Orthop Sci. 2011;16:516–523. doi: 10.1007/s00776-011-0112-9. [DOI] [PubMed] [Google Scholar]
  • 33.Chan D., Saffari S.E., Wong S.B.S., Yeo S.J., Wylde V., Thumboo J., et al. The influence of pain catastrophizing on pain and function after knee arthroplasty in knee osteoarthritis. Sci Rep. 2024;14 doi: 10.1038/s41598-024-67561-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lin A., Liu Z.Q., Yao J.P., Liu Y.H., Wan H. A review of the extent of pain catastrophizing in patients who have undergone total knee replacement. Pain Manag Nurs. 2024;25:e192–e200. doi: 10.1016/j.pmn.2023.12.014. [DOI] [PubMed] [Google Scholar]
  • 35.Pei J., Chen H., Ma T., Zhang Y., Wang X., Li C., et al. Pain catastrophizing and associated factors in preoperative total knee arthroplasty in lanzhou, China: a cross-sectional study. BMC Musculoskelet Disord. 2022;23:507. doi: 10.1186/s12891-022-05435-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Ten Noever de Brauw G.V., Aalders M.B., Kerkhoffs G., Zuiderbaan H.A., Keijser L.C.M., Benner J.L. The mind matters: psychological factors influence subjective outcomes following unicompartmental knee arthroplasty-a prospective study. Knee Surg Sports Traumatol Arthrosc. 2025;33:239–251. doi: 10.1002/ksa.12275. [DOI] [PubMed] [Google Scholar]
  • 37.Bierke S., Häner M., Karpinski K., Hees T., Petersen W. Midterm effect of mental factors on pain, function, and patient satisfaction 5 years after uncomplicated total knee arthroplasty. J Arthroplasty. 2020;35:105–111. doi: 10.1016/j.arth.2019.08.008. [DOI] [PubMed] [Google Scholar]
  • 38.van der List J.P., Benner J.L., Temmerman O.P.P., Keijser L.C.M. Preoperative pain catastrophizing prior to total knee arthroplasty is associated with worse preoperative symptoms and more clinical improvement: a prospective comparative study. J Arthroplasty. 2023;38:470–475. doi: 10.1016/j.arth.2022.09.016. [DOI] [PubMed] [Google Scholar]
  • 39.Hasegawa M., Tone S., Naito Y., Sudo A. Preoperative pain catastrophizing affects pain outcome after total knee arthroplasty. J Orthop Sci. 2022;27:1096–1099. doi: 10.1016/j.jos.2021.05.011. [DOI] [PubMed] [Google Scholar]
  • 40.Kim M.S., Kim J.J., Kang K.H., Lee J.H., In Y. Central sensitization and neuropathic pain cumulatively affect patients reporting inferior outcomes following total knee arthroplasty. J Bone Joint Surg Am. 2024;106:102–109. doi: 10.2106/JBJS.23.00399. [DOI] [PubMed] [Google Scholar]
  • 41.Isaac S.M., Barker K.L., Danial I.N., Beard D.J., Dodd C.A., Murray D.W. Does arthroplasty type influence knee joint proprioception? A longitudinal prospective study comparing total and unicompartmental arthroplasty. The Knee. 2007;14:212–217. doi: 10.1016/j.knee.2007.01.001. [DOI] [PubMed] [Google Scholar]
  • 42.Wodowski A.J., Swigler C.W., Liu H., Nord K.M., Toy P.C., Mihalko W.M. Proprioception and knee arthroplasty: a literature review. Orthop Clin North Am. 2016;47:301–309. doi: 10.1016/j.ocl.2015.09.005. [DOI] [PubMed] [Google Scholar]
  • 43.Tripathy S.K., Varghese P., Srinivasan A., Goyal T., Purudappa P.P., Sen R.K., et al. Joint awareness after unicompartmental knee arthroplasty and total knee arthroplasty: a systematic review and meta-analysis of cohort studies. Knee Surg Sports Traumatol Arthrosc. 2021;29:3478–3487. doi: 10.1007/s00167-020-06327-4. [DOI] [PubMed] [Google Scholar]
  • 44.Kono K., Tomita T., Yamazaki T., Inui H., Tanaka S., D'Lima D.D. In vivo kinematics and cruciate ligament tension are not restored to normal after bicruciate-preserving arthroplasty. J Arthroplasty. 2024;39:S333–S339. doi: 10.1016/j.arth.2024.03.060. [DOI] [PubMed] [Google Scholar]
  • 45.Bosco J.L., Silliman R.A., Thwin S.S., Geiger A.M., Buist D.S., Prout M.N., et al. A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol. 2010 Jan;63:64–74. doi: 10.1016/j.jclinepi.2009.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Ekhtiari S., Worthy T., Winemaker M.J., de V.B.J., Petruccelli D.T., Khanduja V., et al. When does patient function "plateau" after total joint arthroplasty? A cohort study. Int Orthop. 2024;48:2283–2291. doi: 10.1007/s00264-024-06248-8. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Conflict of Interest Statement for Young
mmc1.pdf (271.4KB, pdf)
Conflict of Interest Statement for Kawaguchi
mmc2.pdf (277.8KB, pdf)
Conflict of Interest Statement for Inui
mmc3.pdf (252.5KB, pdf)
Conflict of Interest Statement for Kono
mmc4.pdf (252.4KB, pdf)
Conflict of Interest Statement for Tay
mmc5.pdf (268.6KB, pdf)
Conflict of Interest Statement for Taketomi
mmc6.pdf (253.7KB, pdf)
Conflict of Interest Statement for Tanaka
mmc7.pdf (261.4KB, pdf)
Conflict of Interest Statement for Yamagami
mmc8.pdf (252.6KB, pdf)

Data Availability Statement

The data used for this study are available on reasonable request in writing to the corresponding author.


Articles from Arthroplasty Today are provided here courtesy of Elsevier

RESOURCES